Highlights

Prostate Cancer: New Study Published on Effectiveness of Radiotherapy for Treating Recurrence Recently, the British Journal of Urology published a multicenter retrospective study that assessed the efficacy and the possible toxicity of stereotactic body radiotherapy for patients with macroscopic recurrence in the prostate bed following radical prostatectomy. Numerous specialists were involved in the study, including Prof. […]

UPMC Italy is issuing a call for applications for the following no-term position: 1 Medical Physicist (Ref. FS UPMC/20) UPMC (University of Pittsburgh Medical Center) is a world-renowned healthcare and research enterprise headquartered in Pittsburgh, Pennsylvania, U.S., inventing new models of patient-centered, cost-effective, accountable care. With facilities in Campania, Lazio, Sicily, and Tuscany, UPMC Italy (the Italian division […]

Carlo is 60 years old when he undergoes routine blood chemistry and is told that his PSA levels were above normal limits.  The PSA (prostate-specific antigen) is a protein produced by the prostate, and present in the blood.  High levels of PSA may be related to prostate inflammation or presence of benign or malignant neoplastic […]

What happens when the roles are reversed and the doctor becomes a patient? What happens when a doctor is diagnosed with cancer?  As for everyone, the diagnosis of cancer is devastating news.  The whole world falls apart, and maybe for a doctor – who often faces other people’s diseases and suffering – the disbelief is […]

Thousands of citizens in southern Italy now have access to advanced radiation oncology procedures at the UPMC Hillman Cancer Center at Villa Maria, thanks to a recent accreditation from the regional government.  Earlier in November, the Region of Campania granted institutional accreditation to the newest UPMC Hillman location in Italy, the second in that country, […]

The UPMC Annual Radiotherapy Symposium, entitled “Interactions between New Systemic Therapies and Stereotactic Radiation Treatments”, will take place on December 13th and 14th 2019 in Rome (Residenza di Ripetta) The widespread and steady use of new drugs in oncology has resulted in the need to optimize their interaction and synergy with stereotactic radiation therapies. In […]